Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS
NCT00168766
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
345
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsing-remitting Multiple Sclerosis
Interventions
DRUG:
Interferon-beta-1a (Avonex) plus methylprednisolone
Sponsor
Biogen